Outcomes of Chronic Hepatitis C Therapy in Patients Treated in Community Versus Academic Centres in Canada: Final Results of APPROACH (A Prospective Study of Peginterferon alfa-2a and Ribavirin at Academic and Community Centres in Canada)
BACKGROUND: In patients chronically infected with the hepatitis C virus (HCV), it is not established whether viral outcomes or health-related quality of life (HRQoL) differ between individuals treated at academic or community centres.
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2011-01-01
|
| Series: | Canadian Journal of Gastroenterology |
| Online Access: | http://dx.doi.org/10.1155/2011/698780 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832549489965006848 |
|---|---|
| author | Robert P Myers Curtis Cooper Morris Sherman Richard Lalonde Helga Witt-Sullivan Magdy Elkashab Paul Harris Rob Balshaw Christopher Usaty Paul J Marotta |
| author_facet | Robert P Myers Curtis Cooper Morris Sherman Richard Lalonde Helga Witt-Sullivan Magdy Elkashab Paul Harris Rob Balshaw Christopher Usaty Paul J Marotta |
| author_sort | Robert P Myers |
| collection | DOAJ |
| description | BACKGROUND: In patients chronically infected with the hepatitis C virus (HCV), it is not established whether viral outcomes or health-related quality of life (HRQoL) differ between individuals treated at academic or community centres. |
| format | Article |
| id | doaj-art-11fae779ae104a3f83f0e2227a7a4673 |
| institution | Kabale University |
| issn | 0835-7900 |
| language | English |
| publishDate | 2011-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Canadian Journal of Gastroenterology |
| spelling | doaj-art-11fae779ae104a3f83f0e2227a7a46732025-02-03T06:11:12ZengWileyCanadian Journal of Gastroenterology0835-79002011-01-0125950351010.1155/2011/698780Outcomes of Chronic Hepatitis C Therapy in Patients Treated in Community Versus Academic Centres in Canada: Final Results of APPROACH (A Prospective Study of Peginterferon alfa-2a and Ribavirin at Academic and Community Centres in Canada)Robert P Myers0Curtis Cooper1Morris Sherman2Richard Lalonde3Helga Witt-Sullivan4Magdy Elkashab5Paul Harris6Rob Balshaw7Christopher Usaty8Paul J Marotta9Liver Unit, University of Calgary, Calgary, Alberta, CanadaUniversity of Ottawa, Ottawa, CanadaUniversity Health Network, Toronto, Ontario, CanadaMcGill University, Montreal, Quebec, CanadaMcMaster University, Hamilton, CanadaToronto Liver Centre, Toronto, Ontario, CanadaUniversity of Saskatchewan, Saskatoon, Saskatchewan, CanadaSyreon Corporation, Vancouver, British Columbia, CanadaHoffmann-La Roche Ltd, Mississauga, CanadaUniversity of Western Ontario, London, Ontario, CanadaBACKGROUND: In patients chronically infected with the hepatitis C virus (HCV), it is not established whether viral outcomes or health-related quality of life (HRQoL) differ between individuals treated at academic or community centres.http://dx.doi.org/10.1155/2011/698780 |
| spellingShingle | Robert P Myers Curtis Cooper Morris Sherman Richard Lalonde Helga Witt-Sullivan Magdy Elkashab Paul Harris Rob Balshaw Christopher Usaty Paul J Marotta Outcomes of Chronic Hepatitis C Therapy in Patients Treated in Community Versus Academic Centres in Canada: Final Results of APPROACH (A Prospective Study of Peginterferon alfa-2a and Ribavirin at Academic and Community Centres in Canada) Canadian Journal of Gastroenterology |
| title | Outcomes of Chronic Hepatitis C Therapy in Patients Treated in Community Versus Academic Centres in Canada: Final Results of APPROACH (A Prospective Study of Peginterferon alfa-2a and Ribavirin at Academic and Community Centres in Canada) |
| title_full | Outcomes of Chronic Hepatitis C Therapy in Patients Treated in Community Versus Academic Centres in Canada: Final Results of APPROACH (A Prospective Study of Peginterferon alfa-2a and Ribavirin at Academic and Community Centres in Canada) |
| title_fullStr | Outcomes of Chronic Hepatitis C Therapy in Patients Treated in Community Versus Academic Centres in Canada: Final Results of APPROACH (A Prospective Study of Peginterferon alfa-2a and Ribavirin at Academic and Community Centres in Canada) |
| title_full_unstemmed | Outcomes of Chronic Hepatitis C Therapy in Patients Treated in Community Versus Academic Centres in Canada: Final Results of APPROACH (A Prospective Study of Peginterferon alfa-2a and Ribavirin at Academic and Community Centres in Canada) |
| title_short | Outcomes of Chronic Hepatitis C Therapy in Patients Treated in Community Versus Academic Centres in Canada: Final Results of APPROACH (A Prospective Study of Peginterferon alfa-2a and Ribavirin at Academic and Community Centres in Canada) |
| title_sort | outcomes of chronic hepatitis c therapy in patients treated in community versus academic centres in canada final results of approach a prospective study of peginterferon alfa 2a and ribavirin at academic and community centres in canada |
| url | http://dx.doi.org/10.1155/2011/698780 |
| work_keys_str_mv | AT robertpmyers outcomesofchronichepatitisctherapyinpatientstreatedincommunityversusacademiccentresincanadafinalresultsofapproachaprospectivestudyofpeginterferonalfa2aandribavirinatacademicandcommunitycentresincanada AT curtiscooper outcomesofchronichepatitisctherapyinpatientstreatedincommunityversusacademiccentresincanadafinalresultsofapproachaprospectivestudyofpeginterferonalfa2aandribavirinatacademicandcommunitycentresincanada AT morrissherman outcomesofchronichepatitisctherapyinpatientstreatedincommunityversusacademiccentresincanadafinalresultsofapproachaprospectivestudyofpeginterferonalfa2aandribavirinatacademicandcommunitycentresincanada AT richardlalonde outcomesofchronichepatitisctherapyinpatientstreatedincommunityversusacademiccentresincanadafinalresultsofapproachaprospectivestudyofpeginterferonalfa2aandribavirinatacademicandcommunitycentresincanada AT helgawittsullivan outcomesofchronichepatitisctherapyinpatientstreatedincommunityversusacademiccentresincanadafinalresultsofapproachaprospectivestudyofpeginterferonalfa2aandribavirinatacademicandcommunitycentresincanada AT magdyelkashab outcomesofchronichepatitisctherapyinpatientstreatedincommunityversusacademiccentresincanadafinalresultsofapproachaprospectivestudyofpeginterferonalfa2aandribavirinatacademicandcommunitycentresincanada AT paulharris outcomesofchronichepatitisctherapyinpatientstreatedincommunityversusacademiccentresincanadafinalresultsofapproachaprospectivestudyofpeginterferonalfa2aandribavirinatacademicandcommunitycentresincanada AT robbalshaw outcomesofchronichepatitisctherapyinpatientstreatedincommunityversusacademiccentresincanadafinalresultsofapproachaprospectivestudyofpeginterferonalfa2aandribavirinatacademicandcommunitycentresincanada AT christopherusaty outcomesofchronichepatitisctherapyinpatientstreatedincommunityversusacademiccentresincanadafinalresultsofapproachaprospectivestudyofpeginterferonalfa2aandribavirinatacademicandcommunitycentresincanada AT pauljmarotta outcomesofchronichepatitisctherapyinpatientstreatedincommunityversusacademiccentresincanadafinalresultsofapproachaprospectivestudyofpeginterferonalfa2aandribavirinatacademicandcommunitycentresincanada |